Penn Medicine Abramson Cancer Center
New Therapies and Current Patient Management of Lymphomas
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
Immunotherapy for R/R Mantle Cell Lymphoma - ZUMA-2 Trial of KTE-X19
FEATURING
James Gerson
- 166 views
- February 21, 2020
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
ASH 2019 Updates on Large Cell Lymphoma: Use of ClonoSEQ in Diagnosis, PET-Directed Therapy in Limited-Stage DLBCL, Burkitt Lymphoma Treatment Options & MATRIX-RICE followed by ASCT for CNS Lymphoma
FEATURING
Sunita D. Nasta
- 41 views
- February 25, 2020
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
New Agents in R/R Large Cell Lymphoma: Pola + BR Promising Treatment, Blinatumomab and Lenalidomide Have Limited Efficacy, & Mosunetuzumab Monotherapy Achieves CR in High-Risk Pts
FEATURING
Sunita D. Nasta
- 96 views
- February 25, 2020